QI
DGX icon

Qtron Investments’s Quest Diagnostics DGX Stock Holding History

Qtron Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$819K Sell
3,866
-753
-16% -$148K 0.11% 217
2026
Q1 		$905K Buy
4,619
+3
+0.1% +$583 0.12% 207
2025
Q4 		$801K Sell
4,616
-374
-7% -$68.1K 0.1% 228
2025
Q3 		$951K Buy
4,990
+1,127
+29% +$200K 0.12% 202
2025
Q2 		$694K Hold
3,863
– – 0.09% 270
2025
Q1 		$654K Buy
+3,863
New +$635K 0.1% 259
2023
Q3 		– Sell
-2,496
Closed -$351K – 411
2023
Q2 		$351K Sell
2,496
-1,550
-38% -$214K 0.07% 331
2023
Q1 		$572K Sell
4,046
-760
-16% -$109K 0.12% 239
2022
Q4 		$752K Buy
4,806
+1,869
+64% +$269K 0.16% 182
2022
Q3 		$360K Buy
2,937
+688
+31% +$90.6K 0.09% 299
2022
Q2 		$299K Buy
+2,249
New +$306K 0.07% 329
2022
Q1 		– Sell
-1,960
Closed -$339K – 343
2021
Q4 		$339K Sell
1,960
-3,968
-67% -$604K 0.08% 270
2021
Q3 		$861K Buy
+5,928
New +$867K 0.23% 134

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Qtron Investments's DGX Position: Q2 2026 in Review

Qtron Investments reduced its Quest Diagnostics (DGX) stake by 16% in Q2 2026, selling an estimated $148K and leaving 3,866 shares worth $819K. The position accounts for 0.11% of the portfolio, ranked #217.

Qtron Investments first reported a position in DGX in Q3 2021 and has held it in 13 quarters since. The position peaked at $951K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Qtron Investments held 3,866 shares of Quest Diagnostics worth $819K as of Q2 2026.
  • Qtron Investments sold 753 Quest Diagnostics shares in Q2 2026, an estimated $148K.
  • Quest Diagnostics made up 0.11% of Qtron Investments's portfolio in Q2 2026, its #217 holding.
  • Qtron Investments first reported a position in Quest Diagnostics in Q3 2021 and has held it in 13 quarters since.
  • Qtron Investments's Quest Diagnostics position peaked at $951K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.